NASH
Clinical trials for NASH explained in plain language.
Never miss a new study
Get alerted when new NASH trials appear
Sign up with your email to follow new studies for NASH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Genetic breakthrough drug enters human trials for silent liver killer
Disease control OngoingThis study is testing an experimental drug called VSA006 in Chinese adults with nonalcoholic steatohepatitis (NASH), a serious form of fatty liver disease. The drug works by targeting a specific liver protein linked to disease progression. Researchers will check if the injection …
Matched conditions: NASH
Phase: PHASE2 • Sponsor: Visirna Therapeutics HK Limited • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New scanner could spot fatty liver without MRI
Diagnosis TerminatedThis study aimed to test a new type of ultrasound device for detecting and measuring fat in the liver. Researchers planned to compare the device's accuracy to the current standard method, an MRI scan. The trial was withdrawn before any participants were enrolled.
Matched conditions: NASH
Sponsor: Medical College of Wisconsin • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
New scans aim to spot silent liver damage in obese kids
Diagnosis OngoingThis study is testing new MRI and ultrasound scanning methods to accurately measure fat in children's livers. It involves 24 children, both with obesity and with a healthy weight, to see if these scans are practical and reliable. The goal is to improve the tools doctors use to de…
Matched conditions: NASH
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Diagnosis
Last updated Mar 30, 2026 14:31 UTC